Product Patents
In accordance with 35 U.S.C. § 287(a), the following listing may be used, in conjunction with the FDA-approved prescribing information, to determine the U.S. patents for the products listed below that are marketed in the U.S.; additional patents may be pending in the U.S. and in other countries. The following list may not be all inclusive.
PRODUCT U.S. Patent No.
UKONIQTM (umbralisib) Tablets: 9,150,579
……………………..00000000………………………………………………..9,669,033
…………………….00000000…………………………………………………9,969,740
……………………..00000000……………………………………………….10,072,013
……………………..00000000……………………………………………….10,414,773
……………………….00000000……………………………………………..10,570,142